Urethral cancer surgery
Jump to navigation
Jump to search
|
Urethral cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urethral cancer surgery On the Web |
|
American Roentgen Ray Society Images of Urethral cancer surgery |
|
Risk calculators and risk factors for Urethral cancer surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Surgery is the mainstay of treatment for urethral cancer. However, it is not recommended among patients with metastatic urethral cancer.
Surgery
- Surgery is the mainstay of therapy for urethral cancers in both women and men.
- The surgical approach depends on tumor stage and anatomic location.
- Tumor grade plays a less important role in treatment decisions.
- Although the traditional recommendation has been to achieve a 2-cm tumor-free margin, the optimal surgical margin has not been rigorously studied and is not well defined.[1]
- The role of lymph node dissection is not clear in the absence of clinical involvement, and the role of prophylactic dissection is controversial.
- Ablative techniques, such as transurethral resection, electro-resection and fulguration, or laser vaporization-coagulation, are used to preserve organ function in cases of superficial anterior tumors, although the supporting literature is scant.
- Surgery is the most common treatment for cancer of the urethra. One of the following types of surgery may be done:
- Surgery is not recommended among patients with metastatic urethral cancer.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq